Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "abt"

Abbott Laboratories Shares Climbing Higher, Up 2.2%

Up 2.2% to $45.24, Abbott Laboratories (NYSE:ABT), is one of today's notable movers. The S&P is trading higher by 1.3% to 2,039 and the Dow is trading 1.3% higher Individual.com, 5 hours ago

150 images for abt

One News Page United Kingdom, 4 hours ago
Value Research Online, 14 hours ago
MassDevice, 1 day ago
BusinessWeek, 2 days ago
People Daily, 1 week ago
Seeking Alpha, 1 week ago
Warwick Daily News, 4 days ago
Warwick Daily News, 4 days ago
Warwick Daily News, 4 days ago
Warwick Daily News, 4 days ago

Two ABT cadres arrested in Dhaka city

 South Asian Terrorism Portal12 hours ago 2 Ansarullah Bangla Team members held in city  Bangladesh Sangbad Sangstha1 day ago

What would an FDA OK on AbbVie's hep C cocktail mean for payers?

When AbbVie spun off from Abbott ( $ABT ) two years ago, it had one giant plus in its favor: the world's top-selling drug Humira. R&D, though, hasn't been very productive in the past decade in terms of new drug approvals. After Humira's $12.5 ...
 FierceBiotech6 hours ago Better Big Pharma Spinoff: Zoetis Inc. or AbbVie Inc.?  Motley Fool1 day ago

AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax ABT-199/GDC-0199 in Acute Myelogenous Leukemia at the 56th American...

AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax ABT-199/GDC-0199 in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting By a News Reporter-Staff News Editor at Cancer Weekly -- ...
 4 Traders20 hours ago AbbVie : Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199) in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting  4 Traders1 week ago ABBVIE : releases results from phase II study of venetoclax in acute myelogenous Leukemia  4 Traders1 week ago
[x]  

Abbott Laboratories (ABT) Showing Support Near $42.71

The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Abbott Laboratories (http://www.marketintelligencecenter.com/symbol/ABT"ABT) that should provide a 4.17% return in just 66 days. Sell ...
 Individual.com2 days ago Abbott tests the power of a Big Pharma name with international branding push  FiercePharma1 week ago Abbott Laboratories (ABT) Showing Bullish Technicals With Support At $43.81  Individual.com6 days ago Next Support Level for Abbott Laboratories (ABT) is $44.96  Individual.com1 week ago
ClinicSpace

Abbott completes acquisition of Veropharm

Abbott (NYSE: ABT) today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commitment to growing global ...
 European Pharmaceutical Review3 days ago Abbott to Present at J.P. Morgan Healthcare Conference  Reuters8 hours ago Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022  European Pharmaceutical Review2 days ago Abbott completes acquisition of Russian drug maker  Seeking Alpha6 days ago
[x]  

Abbott's board to pay higher quarterly dividend of USD0.24 per share

The board of directors of Abbott (NYSE:ABT), a healthcare company, declared on Friday its dividend of USD0.24 per share of its common stock. This is an improvement from the prior cash dividend of USD0.22 per share, it also marks the 43rd ...
 BusinessWeek3 days ago Abbott raises quarterly dividend to 24 cents a share from 22 cents  TD Ameritrade6 days ago
CBS News

​Excerpt: Misty Copeland's "Firebird"

The ABT ballerina's first children's book shows how to reach soaring heights through hard work
 CBS News5 days ago

Abbott reports purchase of Russian pharmaceutical company Veropharm

Healthcare company Abbott (NYSE:ABT) disclosed on Thursday that it has completed the acquisition of the control of the Russian pharmaceutical company, Veropharm. Abbott said it has acquired control of Veropharm for RUB16.7bn through its purchase of ...
 BusinessWeek6 days ago

In a Director's Viewpoint of ABT's White Christmas

I spent time with White Christmas director/choreographer Stephen Casey and music director Mark 4Man. Mr. Casey, a resident of Philadelphia, has an extensive background in directing and choreography. He is making his debut in these positions with ...
 Delaware Newszap1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less